BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6197447)

  • 1. Serologically detectable polymorphism of the HLA-DC alpha-subunit.
    Tosi R; Tanigaki N; Sorrentino R; Centis D; Ferrara GB
    J Immunol; 1984 Jan; 132(1):277-82. PubMed ID: 6197447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA-DR antigens: cellular expression and molecular structure].
    Charron DJ
    Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DR5-associated DC molecules carry three different allospecificities.
    Tanigaki N; Tosi R; Centis D; Ferrara GB
    Hum Immunol; 1985 Jan; 12(1):47-57. PubMed ID: 3871759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
    Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH
    Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody to the HLA-DR product recognizes a polymorphic Ia determinant in mice.
    Brickell PM; McConnell I; Milstein C; Wright B
    Immunology; 1981 Jul; 43(3):493-501. PubMed ID: 6166548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells.
    Giles RC; Hurley CK; Capra JD
    J Immunol; 1984 Jul; 133(1):1-3. PubMed ID: 6609970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity.
    Gorski J; Mach B
    Nature; 1986 Jul 3-9; 322(6074):67-70. PubMed ID: 3459965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of anti-DQ alloantisera correlated with DR5.
    Crepaldi T; Fasano ME; Frattasio C; Centis D; Curtoni ES; Richiardi P
    J Immunogenet; 1985 Dec; 12(6):301-8. PubMed ID: 2426368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human B cell alloantigens: expression of MB and MT determinants.
    Markert ML; Cresswell P
    J Immunol; 1982 May; 128(5):2004-8. PubMed ID: 6174619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities.
    Tanigaki N; Tosi R
    Immunol Rev; 1982; 66():5-37. PubMed ID: 6182090
    [No Abstract]   [Full Text] [Related]  

  • 13. The human HLA-DR antigens are encoded by multiple beta-chain loci.
    Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD
    J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DA6-147 monoclonal antibody raised against the HLA-DR alpha chain identifies a cryptic epitope on the BoLA-DR alpha chain.
    Ababou A; Davis WC; Levy D
    Vet Res; 1993; 24(5):402-7. PubMed ID: 7505154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.
    Radka SF; Machamer C; Cresswell P; Kostyu DD; Ward FE; Amos DB
    J Immunol; 1983 Apr; 130(4):1863-6. PubMed ID: 6187822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of polymorphism of HLA class II genes using synthetic oligonucleotides].
    Le Gall I; Millasseau P; Dausset J; Cohen D
    C R Acad Sci III; 1985; 301(15):669-73. PubMed ID: 3935278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that celiac disease is primarily associated with a DC locus allelic specificity.
    Tosi R; Vismara D; Tanigaki N; Ferrara GB; Cicimarra F; Buffolano W; Follo D; Auricchio S
    Clin Immunol Immunopathol; 1983 Sep; 28(3):395-404. PubMed ID: 6192959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical analysis of the polymorphism of three HLA-D region antigens.
    de Kretser T; Crumpton MJ; Bodmer JG; Bodmer WF
    Mol Biol Med; 1983 Jul; 1(1):59-76. PubMed ID: 6593560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens.
    Kasahara M; Ikeda H; Ogasawara K; Ishikawa N; Okuyama T; Fukasawa Y; Kojima H; Kunikane H; Hawkin S; Ohhashi T
    Immunology; 1984 Sep; 53(1):79-86. PubMed ID: 6205985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.